Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies.

Salani S, Donadoni C, Rizzo F, Bresolin N, Comi GP, Corti S.

J Cell Mol Med. 2012 Jul;16(7):1353-64. doi: 10.1111/j.1582-4934.2011.01498.x. Review.

2.

Stem cell therapies to treat muscular dystrophy: progress to date.

Meregalli M, Farini A, Parolini D, Maciotta S, Torrente Y.

BioDrugs. 2010 Aug 1;24(4):237-47. doi: 10.2165/11534300-000000000-00000. Review.

PMID:
20623990
3.

Myogenic Progenitors from Mouse Pluripotent Stem Cells for Muscle Regeneration.

Magli A, Incitti T, Perlingeiro RC.

Methods Mol Biol. 2016;1460:191-208. doi: 10.1007/978-1-4939-3810-0_14.

PMID:
27492174
4.

Concise review: stem cell therapy for muscular dystrophies.

Wilschut KJ, Ling VB, Bernstein HS.

Stem Cells Transl Med. 2012 Nov;1(11):833-42. doi: 10.5966/sctm.2012-0071. Epub 2012 Oct 23. Review.

5.

Engraftment of embryonic stem cell-derived myogenic progenitors in a dominant model of muscular dystrophy.

Darabi R, Baik J, Clee M, Kyba M, Tupler R, Perlingeiro RC.

Exp Neurol. 2009 Nov;220(1):212-6. doi: 10.1016/j.expneurol.2009.08.002. Epub 2009 Aug 13.

6.

Derivation of myogenic progenitors directly from human pluripotent stem cells using a sphere-based culture.

Hosoyama T, McGivern JV, Van Dyke JM, Ebert AD, Suzuki M.

Stem Cells Transl Med. 2014 May;3(5):564-74. doi: 10.5966/sctm.2013-0143. Epub 2014 Mar 21.

7.

Derivation of Skeletal Myogenic Precursors from Human Pluripotent Stem Cells Using Conditional Expression of PAX7.

Darabi R, Perlingeiro RC.

Methods Mol Biol. 2016;1357:423-39. doi: 10.1007/7651_2014_134.

PMID:
25403466
8.

The potential for treatment of skeletal muscle disorders with adipose-derived stem cells.

Mizuno H.

Curr Stem Cell Res Ther. 2010 Jun;5(2):133-6. Review.

PMID:
19941455
9.

Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells.

Mizuno Y, Chang H, Umeda K, Niwa A, Iwasa T, Awaya T, Fukada S, Yamamoto H, Yamanaka S, Nakahata T, Heike T.

FASEB J. 2010 Jul;24(7):2245-53. doi: 10.1096/fj.09-137174. Epub 2010 Feb 24.

PMID:
20181939
10.

Current advances in cell therapy strategies for muscular dystrophies.

Negroni E, Vallese D, Vilquin JT, Butler-Browne G, Mouly V, Trollet C.

Expert Opin Biol Ther. 2011 Feb;11(2):157-76. doi: 10.1517/14712598.2011.542748. Review.

PMID:
21219234
11.

The origin, molecular regulation and therapeutic potential of myogenic stem cell populations.

Otto A, Collins-Hooper H, Patel K.

J Anat. 2009 Nov;215(5):477-97. doi: 10.1111/j.1469-7580.2009.01138.x. Epub 2009 Aug 24. Review.

12.

Adult Stem Cells and Skeletal Muscle Regeneration.

Costamagna D, Berardi E, Ceccarelli G, Sampaolesi M.

Curr Gene Ther. 2015;15(4):348-63. Review.

PMID:
26122100
13.

Human skeletal muscle-derived CD133(+) cells form functional satellite cells after intramuscular transplantation in immunodeficient host mice.

Meng J, Chun S, Asfahani R, Lochmüller H, Muntoni F, Morgan J.

Mol Ther. 2014 May;22(5):1008-17. doi: 10.1038/mt.2014.26. Epub 2014 Feb 26.

14.

Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice.

Darabi R, Arpke RW, Irion S, Dimos JT, Grskovic M, Kyba M, Perlingeiro RC.

Cell Stem Cell. 2012 May 4;10(5):610-9. doi: 10.1016/j.stem.2012.02.015.

15.

Mesodermal iPSC-derived progenitor cells functionally regenerate cardiac and skeletal muscle.

Quattrocelli M, Swinnen M, Giacomazzi G, Camps J, Barthélemy I, Ceccarelli G, Caluwé E, Grosemans H, Thorrez L, Pelizzo G, Muijtjens M, Verfaillie CM, Blot S, Janssens S, Sampaolesi M.

J Clin Invest. 2015 Dec;125(12):4463-82. doi: 10.1172/JCI82735. Epub 2015 Nov 16.

16.

Pluripotent stem cell derivation and differentiation toward cardiac muscle: novel techniques and advances in patent literature.

Quattrocelli M, Thorrez L, Sampaolesi M.

Recent Pat Drug Deliv Formul. 2013 Apr;7(1):18-28. Review.

PMID:
22974171
17.

Cell therapy strategies and improvements for muscular dystrophy.

Quattrocelli M, Cassano M, Crippa S, Perini I, Sampaolesi M.

Cell Death Differ. 2010 Aug;17(8):1222-9. doi: 10.1038/cdd.2009.160. Epub 2009 Oct 30. Review.

18.

Transplantation of induced pluripotent stem cell-derived mesoangioblast-like myogenic progenitors in mouse models of muscle regeneration.

Gerli MF, Maffioletti SM, Millet Q, Tedesco FS.

J Vis Exp. 2014 Jan 20;(83):e50532. doi: 10.3791/50532.

19.

Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation.

Goudenege S, Lebel C, Huot NB, Dufour C, Fujii I, Gekas J, Rousseau J, Tremblay JP.

Mol Ther. 2012 Nov;20(11):2153-67. doi: 10.1038/mt.2012.188. Epub 2012 Sep 18.

20.

Stem cell based therapies to treat muscular dystrophy.

Price FD, Kuroda K, Rudnicki MA.

Biochim Biophys Acta. 2007 Feb;1772(2):272-83. Epub 2006 Sep 6. Review.

Supplemental Content

Support Center